Discover the Science Behind Arthramid® 2.5% iPAAG

Arthramid is trusted by veterinarians around the world to treat joint lameness in animals, including horses and dogs. Backed by multiple published studies from leading institutions and with thousands of successful treatments across a range of species and disciplines, Arthramid is a proven, safe, and effective option for managing osteoarthritis and joint-related conditions in veterinary medicine.

Clinical Studies

Synovial incorporation of polyacrylamide hydrogel after injection into normal and osteoarthritic animal joints
Christensen, L., Illigen, K.E., Hansen, M., Sarvaa, R., and Conogham, P.G. (2016).
Use of a 2.5% Cross-Linked Polyacrylamide Hydrogel in the Management of Joint Lameness in a Population of Flat Racing Thoroughbreds: A Pilot Study
de Clifford, L.D., Lowe, J.N., McKellar, C.D., Bolwell, C., and David, F. Journal of Equine Veterinary Science. 2019

Arthramid White Papers

EQUINE WHITE PAPER

Veterinarians: Get your copy of our 24 page white paper today, covering Treatment of Joint Lameness, Pathophysiology, Manufacturing, Mechanism of Action, Clinical Safety and Putting it into Practice.

DOWNLOAD NOW

CANINE WHITE PAPER

Veterinarians: Get your copy of our 21 page white paper today, covering Treatment of Joint Lameness, Pathophysiology, Manufacturing, Mechanism of Action, Clinical Safety and Putting it into Practice.

DOWNLOAD NOW

Talk to us for more information

Contact Us

Get The White Paper